© 1994 Oxford University Press
research-article |
Different fates of camptothecin-induced replication fork-associated double-strand DNA breaks in mammalian cells
Cancer Research Campaign Mammalian Cell DNA Repair Group, Department of Zoology, University of Cambridge Cambridge CB2 3EJ, UK
The S phase cytotoxicity of camptothecin (CPT) requires both the formation of a covalent topoisomerase I-DNA complex and ongoing DNA replication. The interaction of DNA synthesis and the drug-induced complexes results in the production of DNA double-strand breaks (DSBs) concentrated in replicating DNA. These DSBs are likely to be extremely cytotoxic lesions and are likely to account for the S phase specificity of CPT. Here we show that a brief exposure to CPT results in replication-associated DSBs and, once formed, the fate of these DNA DSBs is different in human and Chinese hamster cell lines. In hamster CHO-KI, even at supra-lethal concentrations, CPT-induced DSBs in nascent DNA disappear within 5 h of drug removal. Those CHO-KI cells in S phase during treatment with toxic doses of CPT arrive at mitosis within 18 h, with potentially lethal chromatid aberrations. In human cells, CPT-induced DSBs are long lived, and are still detectable at least 24 h after drug removal. After toxic doses of CPT to S phase human cells, mitosis does not occur within 72 h of drug removal and there is an extended, perhaps permanent, cycle arrest in S/G2, possibly due to the presence of unrepaired DNA DSBs. These data, and the greater sensitivity of hamster than human cells to low doses of CPT, suggests that, besides the generation of replication fork-associated DNA DSBs, subsequent processing/repair of these lesions may modulate the sensitivity of cells to this important anti-tumour drug.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. F. El-Khamisy and K. W. Caldecott TDP1-dependent DNA single-strand break repair and neurodegeneration Mutagenesis, July 1, 2006; 21(4): 219 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ferrara and E. B. Kmiec Camptothecin enhances the frequency of oligonucleotide-directed gene repair in mammalian cells by inducing DNA damage and activating homologous recombination Nucleic Acids Res., October 5, 2004; 32(17): 5239 - 5248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Interthal, P. M. Quigley, W. G. J. Hol, and J. J. Champoux The Role of Lysine 532 in the Catalytic Mechanism of Human Topoisomerase I J. Biol. Chem., January 23, 2004; 279(4): 2984 - 2992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. S. Cho and Y. S. Cho-Chung Antisense Protein Kinase A RI{alpha} Acts Synergistically with Hydroxycamptothecin to Inhibit Growth and Induce Apoptosis in Human Cancer Cells: Molecular Basis for Combinatorial Therapy Clin. Cancer Res., March 1, 2003; 9(3): 1171 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chaturvedi, V. Sudakin, M. L. Bobiak, P. W. Fisher, M. R. Mattern, S. A. Jablonski, M. R. Hurle, Y. Zhu, T. J. Yen, and B.-B. S. Zhou Chfr Regulates a Mitotic Stress Pathway through its RING-Finger Domain with Ubiquitin Ligase Activity Cancer Res., March 1, 2002; 62(6): 1797 - 1801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Vanhoefer, A. Harstrick, W. Achterrath, S. Cao, S. Seeber, and Y. M. Rustum Irinotecan in the Treatment of Colorectal Cancer: Clinical Overview J. Clin. Oncol., March 1, 2001; 19(5): 1501 - 1518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. Huang, S. M. Wuerzberger-Davis, B. J. Seufzer, S. D. Shumway, T. Kurama, D. A. Boothman, and S. Miyamoto NF-kappa B Activation by Camptothecin. A LINKAGE BETWEEN NUCLEAR DNA DAMAGE AND CYTOPLASMIC SIGNALING EVENTS J. Biol. Chem., March 24, 2000; 275(13): 9501 - 9509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Clarke, J. F. Gimenez-Abian, H. Tonnies, H. Neitzel, K. Sperling, C. S. Downes, and R. T. Johnson Creation of monosomic derivatives of human cultured cell lines PNAS, January 6, 1998; 95(1): 167 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Melton, A. Ketchen, F Nunez, S Bonatti-Abbondandolo, A Abbondandolo, S Squires, and R. Johnson Cells from ERCC1-deficient mice show increased genome instability and a reduced frequency of S-phase-dependent illegitimate chromosome exchange but a normal frequency of homologous recombination J. Cell Sci., January 2, 1998; 111(3): 395 - 404. [Abstract] [PDF]
|
|
|
|
|
|
S. D. Desai, L. F. Liu, D. Vazquez-Abad, and P. D'Arpa Ubiquitin-dependent Destruction of Topoisomerase I Is Stimulated by the Antitumor Drug Camptothecin J. Biol. Chem., September 26, 1997; 272(39): 24159 - 24164. [Abstract] [Full Text] [PDF]
|
|